Showing 1 - 10 of 787,761
-line extension (an upgrade through innovation) before it faces generic competition. There are two types of physicians: loyal … competition ; pharmaceutical markets ; innovation …
Persistent link: https://www.econbiz.de/10009355566
more agressive, which triggers price competition and potentially deters entry by generic producers. To investigate the … branded and generic drug prices and branded market shares. Despite fiercer price competition, the number of generic producers …
Persistent link: https://www.econbiz.de/10013285854
and competition with generics. The nature of demand for drugs, the identity of drugs brought to market, and the nature of … competition in the drug market over time are all shaped by regulation. Throughout much of the world, administrative regulation …, rather than competition policy, dominates efforts to afford consumers and governments adequate access to affordable drugs …
Persistent link: https://www.econbiz.de/10012980141
The theoretical relationship between market structure (number of firms) and conduct (pricing behavior) of the generic drug industry was investigated. The effects of qualitative variables such as therapeutic category, duration of use, popularity, and market entry aggressiveness on the...
Persistent link: https://www.econbiz.de/10013128541
In the pharmaceuticals sector there is an inherent tension between intellectual property rights and antitrust. This … paper examines this tension over the past 10 years since modernisation of EU competition law. It looks at three types of … relevant product market, facilitating a finding of dominance. Some national competition authorities have followed in the …
Persistent link: https://www.econbiz.de/10013016118
One approach that antitrust enforcement authorities use to address potentially anticompetitive mergers is to seek divestitures in specific, competitively problematic overlap markets while allowing the rest of the merger to consummate. We evaluate the efficacy of this approach by studying...
Persistent link: https://www.econbiz.de/10013295031
We investigate the welfare impact of parallel imports using a large panel data set containing monthly information on sales, ex-factory prices, and further product characteristics for all 700 anti-diabetic drugs sold in Germany between 2004 and 2010. We estimate a two-stage nested logit model of...
Persistent link: https://www.econbiz.de/10010338113
-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference …
Persistent link: https://www.econbiz.de/10010489291
We investigate the welfare impact of parallel imports using a large panel data set containing monthly information on sales, ex-factory prices, and further product characteristics for all 700 antidiabetic drugs sold in Germany between 2004 and 2010. We estimate a two-stage nested logit model of...
Persistent link: https://www.econbiz.de/10010481411
We investigate the welfare impact of parallel imports using a large panel data set containing monthly information on sales, ex-factory prices, and further product characteristics for all 700 anti-diabetic drugs sold in Germany between 2004 and 2010. We estimate a two-stage nested logit model of...
Persistent link: https://www.econbiz.de/10010339071